• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Molecular constructions of oligodeoxynucleotides binding to bFGF targeting for angiogenesis

Research Project

Project/Area Number 09470172
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKagoshima University

Principal Investigator

KITAJIMA Isao  Faculty of Medicine, Kagoshima University, Associate, 医学部, 助教授 (50214797)

Co-Investigator(Kenkyū-buntansha) UNOKI Kazuhiko  Medical Hospital, Kagoshima University, Associate Professor, 医学部・附属病院, 講師 (60193926)
AKASHI Mitsuru  Faculty of Engineering, Kagoshima University, Professor, 工学部, 教授 (20145460)
MARUYAMA Ikuro  Faculty of Medicine, Kagoshima University, Professor, 医学部, 教授 (20082282)
Project Period (FY) 1997 – 1999
KeywordsAngiogenesis / oligodeoxynucleotides / phosphorothioate / bFGF / NF-κB / cornel vascular / Tube formation / antiseise oligodeoxynucleotides
Research Abstract

Angiogenesis is regulated by heparin-binding growth factors such as basic fibroblast growth factor. In this study, we investigated the effects of phosphorothioate oligodeoxynucleotides on basic fibroblast growth factor induced angiogenesis in vitro and in vivo. Antisense phosphorothioate oligonucleotides are widely used as specific inhibitors of gene expression. Because phosphorothioate-type oligonucleotides are polyanions, they can also bind many heparin-binding proteins. In an electrophoretic mobility shift assay, phosphorothioate oligonucleotides bound basic fibroblast growth factor in a dose-dependent but sequence-independent manner. However, double-strand phosphothioate oligonucleotide-DNAs did not affect complex formation. On a basement matrix using a Matrigel matrix, we observed less than 50% tube formation by human umbilical endothelial cells with 10 uM basic fibroblast growth factor, vascular endothelial growth factor or Nuclear factor kappa B antisense as well as sense phosph … More orotiate oligodeoxynucleotides, while phosphodiester-type oligodeoxynucleotides were not affected. This effect could be overcome by addition of 1 ug/ml basic fibroblast growth factor. The phosphorothioate but not phosphodiester oligodeoxynucleotides also inhibited the basic fibroblast growth factor-induced rabbit corneal neovascularization. The incubation of basic fibroblast growth factor with nuclear factor-kappa B antisense sequence containing four contiguous guanosine residues significantly abrogated the effects of basic fibroblast growth factor. The nuclear factor-kappa B antisense phosphorotioate oligodeoxynucleotides also showed a low rescue score for basic fibroblast growth factor-dependent photoreceptor rescue due to its degradation by constant light exposer in albino rats. However, antisense phosphorothioate oligodeoxynucleotides active against basic fibroblast growth factor inhibited angiogenesis more strongly than the phosphorothioats oligodeoxynucleotides containing four guanosines. Because of the important role basic fibroblast growth factor plays in angiogenesis, some phosphorothioate oligodeoxynucleotides may serve as potent anti-angiogenic compounds acting through a combination of polyanionic phosphorothioate effects and a sequence-specific antisense mechanism. Less

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Takahashi K, Kitajima I: "Hydrostatic pressure induces expression of interleukin 6 and TNF-a mRNA in a chondrocyte like cell line"Annal. Rheum. Dis.. 57. 231-236 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeno N, Kitajima I: "Increased serum level of vascular endothelial growth factor in kawasaki disease"Pediatric Res.. 44. 596-599 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Watanabe O, Kitajima I: "overproduction of vascular endothelial growth factor/ vascular permiability factor causative in CROW-FUKASE(POEMS) syndrome"Muscle Nerve. 21. 1390-1397 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sarker KP, Kitajima I: "Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic receptor signaling inhibitor"Thromb. Haemost.. 82. 1071-1077 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ebisawa T, Kitajima I: "Characterization of bone morphogenic protein-6 signaling pathways in osteoblastdifferentiation"J. Cell Sci.. 112. 3519-3529 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima I, Unoki K: "Phosphorothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo"Antisense and Nucleic Acid Drug Development. 9. 233-239 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 北島勲、丸山征郎: "VEGFと血管、リンパ管形成、細胞増殖因子の作用と疾患"羊土社. 124 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 北島勲、丸山征郎: "NOと骨代謝、心血管病態とNO"金芳堂. 210 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takahashi K, Kubo T, Arai Y, Kitajima I, Takigawa M, and Hirasawa Y: "Hydrostatic pressure induces expression of interleukin 6 and TNF-a mRNA in a chondrocyte like cell line"Ann Rheum Dis. 57. 231-236 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeno N, Takei S, Akaike H, Matsuo K, Kitajima I, Maruyama I, and Miyata K: "Increased serum levels of vascular endothelial growth factor in Kawasaki disease."Pediat Res. 44. 596-599 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, Matsuo K, Arisato T, and Osame M: "Overproduction of vascular endothelial growth factor/vascular permeability factor causative in CROW-FUKASE (POEMS) syndrome."Muscle Nerve. 21. 1390-1397 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sarker KP, Abeyama K, Nishi J-I, Nakata M, Tokioka T, Nakajima T, Kitajima I, and Maruyama I: "Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic receptor signalling inhibitor"Thromb. Haemost.. 82. 1071-1077 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, and Imamura T.: "Characterization of bone morphogenic protein-6 signaling pathways in osteoblast diffentiation."J. Cell Sci.. 112. 3519-3527 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima I, Unoki K, and Maruyama I: "Phosphorothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vito and in vivo."Antisense Nucleic Acid Drug Dev.. 9. 233-239 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi